BSG and lung carcinoma: Increasing extracellular matrix metalloproteinase inducer (emmPrIN) levels in lung cancer cells upregulated the β-catenin signaling pathway, and silencing emmPrIN inhibited β-catenin signaling, cell migration, proliferation, anchorage independent growth, and xenograft growth [36].